Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.44 |
| ▸ | RXRA | P19793 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.33 |
| ▸ | BAD | Q92934 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL56361 | 0.90 | MAPT (0.40) | MAPTSMN1; SMN2HSD17B10ESR1ESR2 | |
| SCHEMBL4502407 | 0.89 | SMN1; SMN2 (0.60) | MAPTSMN1; SMN2L3MBTL1ALDH1A1BCL2L1 | |
| SCHEMBL9514759 | 0.89 | HSD17B1 (0.60) | MAPTSMN1; SMN2HSD17B1HSD17B10ESR1 | |
| SCHEMBL21133359 | 0.87 | HSD17B1 (0.37) | MAPTSMN1; SMN2HSD17B1RXRARXRB | |
| SCHEMBL10583063 | 0.87 | CYP3A4 (0.52) | MAPTSMN1; SMN2HSD17B1RXRARXRB | |
| SCHEMBL22991441 | 0.87 | TPMT (0.41) | MAPTSMN1; SMN2HSD17B1RXRARXRB | |
| SCHEMBL23268269 | 0.87 | HSD17B1 (0.37) | MAPTSMN1; SMN2HSD17B1RXRARXRB | |
| SCHEMBL7596929 | 0.87 | MAPT (0.38) | MAPTSMN1; SMN2HSD17B10ESR1ESR2 | |
| SCHEMBL28660752 | 0.87 | MAPT (0.38) | MAPTSMN1; SMN2HSD17B10ESR1ESR2 | |
| SCHEMBL102795 | 0.85 | MAPT (0.50) | MAPTSMN1; SMN2HSD17B1RXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4308360-A | CROSSLINKING | STANDARD OIL COMPANY (INDIANA) (US) | 1981-12-29 | — | — | US | claimed |
| CN-116285378-B | Resin composition, adhesive sheet containing same, and metal foil-clad laminate | 广东生益科技股份有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119285949-A | Low dielectric resin, resin composition and application thereof | 安徽觅拓材料科技有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-116410594-B | Resin composition, prepreg and metal foil-clad laminate | 广东生益科技股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-116410594-A | Resin composition, prepreg and metal foil-clad laminate | 广东生益科技股份有限公司 | 2023-07-11 | — | — | CN | disclosed |
| CN-116285378-A | Resin composition, adhesive sheet containing same, and metal foil-clad laminate | 广东生益科技股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| US-11548984-B2 | Light- or heat-curing method and curable resin composition | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2023-01-10 | — | — | US | disclosed |
| US-10774062-B2 | Photocuring method, compound and composition used therein | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2020-09-15 | — | — | US | disclosed |
| EP-3409709-B1 | PHOTOCURING METHOD, COMPOUND AND COMPOSITION USED THEREIN | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2020-08-19 | — | — | EP | disclosed |
| EP-3327002-B1 | ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2020-08-19 | — | — | EP | disclosed |
| EP-0103868-B1 | IMPROVED ELECTRICAL INSULATING OIL AND OIL-FILLED ELECTRICAL APPLIANCES | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1987-04-08 | — | — | EP | disclosed |
| EP-0197303-A2 | Electrical insulating materials | Nippon Petrochemicals Co., Ltd. (JP) | 1986-10-15 | — | — | EP | disclosed |
| US-4603101-A | Photoresist compositions containing t-substituted organomethyl vinylaryl ether materials | GENERAL ELECTRIC COMPANY (US) | 1986-07-29 | — | — | US | disclosed |
| EP-0174378-A1 | Electrical-insulating oil and oil-filled electrical appliances | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1986-03-19 | — | — | EP | disclosed |
| US-4543207-A | ORGANIC ACID ESTERS, AROMATIC ETHERS, ANIMAL OILS, VEGETABLE OILS,AND AROMATIC OLEFINS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1985-09-24 | — | — | US | disclosed |
| US-4506107-A | CAPACITORS, CABLES, TRANSFORMERS, PLASTICS | NIPPON PETROCHEMICAL COMPANY, LIMITED (JP) | 1985-03-19 | — | — | US | disclosed |
| US-4493943-A | MIXTURES OF DIARYLALKANES AND AROMATIC MONO-OR DI-OLEFINS | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1985-01-15 | — | — | US | disclosed |
| EP-0114385-A2 | Electrical insulating oil and oil-filled electrical appliances | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1984-08-01 | — | — | EP | disclosed |
| EP-0103868-A2 | Improved electrical insulating oil and oil-filled electrical appliances | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1984-03-28 | — | — | EP | disclosed |
| US-4308360-A | CROSSLINKING | STANDARD OIL COMPANY (INDIANA) (US) | 1981-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10774062-B2 | Photocuring method, compound and composition used therein | ESD, TMT1A, PAM | MAPT 2301/4885SMN1; SMN2 3003/4885HSD17B1 2511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.